Evidence for a M1 muscarinic receptor on the endothelium of human pulmonary veins

British Journal of Pharmacology

Volumn 130, Issue 1, 2000, Pages 73-78

  Walch, Laurence ^a   Gascard, Jean Pierre ^a   Dulmet, Elisabeth ^a   Brink, Charles ^a   Norel, Xavier ^a  

^a CENTRE CHIRURGICAL MARIE LANNELONGUE   (France)

Author keywords

Acetylcholine; Darifenacin; Endothelium; Himbacine; Human pulmonary artery; Human pulmonary vein; Methoctramine; Muscarinic receptor; pFHHSiD; Pirenzepine

Indexed keywords

ACETYLCHOLINE; ATROPINE; DARIFENACIN; FLUOROHEXAHYDROSILADIFENIDOL HYDROCHLORIDE; HIMBACINE; METHOCTRAMINE; MUSCARINIC M1 RECEPTOR; MUSCARINIC RECEPTOR BLOCKING AGENT; NORADRENALIN; PIRENZEPINE; UNCLASSIFIED DRUG;

ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; ENDOTHELIUM CELL; HUMAN; HUMAN TISSUE; PHARMACOKINETICS; PRIORITY JOURNAL; PULMONARY VEIN; RECEPTOR BINDING; SMOOTH MUSCLE RELAXATION; VASODILATATION;

EID: 0034017337     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0703301     Document Type: Article

References (53)

1. ALTIERE, R.J., TRAVIS, D.C., ROBERTS, J. & THOMPSON, D.C. (1994). Pharmacological characterization of muscarinic receptors mediating acetylcholine-induced contraction and relaxation in rabbit intrapulmonary arteries. J. Pharmacol. Exp. Ther., 270, 269-276.
2. BOLDEN, C., CUSACK, B. & RICHELSON, E. (1992). Antagonism by antimuscarinic and neuroleptic compounds at the five cloned human muscarinic cholinergic receptors expressed in Chinese hamster ovary cells. J. Pharmacol. Exp. Ther., 260, 576-580.
3. BROWN, D.A., FORWARD, A. & MARSH, S. (1980). Antagonist discrimination between ganglionic and ileal muscarinic receptors. Br. J. Pharmacol., 71, 362-364.
4. BRUNING, T.A., CHANG, P.C., HENDRIKS, M.G., VERMEIJ, P., PFAFFENDORF, M. & VAN ZWIETEN, P.A. (1995). In vivo characterization of muscarinic receptor subtypes that mediate vasodilatation in patients with essential hypertension. Hypertension, 26, 70-77.
5. BRUNNER, F., KUHBERGER, E., GROSCHNER, K., POCH, G. & KUKOVETZ, W.R. (1991). Characterization of muscarinic receptors mediating endothelium-dependent relaxation of bovine coronary artery. Eur. J. Pharmacol., 200, 25-33.
6. BUCKLEY, N.J., BONNER, T.I., BUCKLEY, C.M. & BRANN, M.R. (1989). Antagonist binding properties of five cloned muscarinic receptors expressed in CHO-K1 cells. Mol. Pharmacol., 35, 469-476.
7. BUZZARD, C.J., PFISTER, S.L. & CAMPBELL, W.B. (1993). Endothelium-dependent contractions in rabbit pulmonary artery are mediated by thromboxane A2. Circ. Res., 72, 1023-1034.
8. CAULFIELD, M.P. & BIRDSALL, N.J. (1998). International Union of Pharmacology. XVII. Classification of muscarinic acetylcholine receptors. Pharmacol. Rev., 50, 279-290.
9. CEMBALA, T.M., SHERWIN, J.D., TIDMARSH, M.D., APPADU, B.L. & LAMBERT, D.G. (1998). Interaction of neuromuscular blocking drugs with recombinant human m1-m5 muscarinic receptors expressed in Chinese hamster ovary cells. Br. J. Pharmacol., 125, 1088-1094.
10. CHAND, N. (1981). 5-hydroxytryptamine induces relaxation of goat pulmonary veins: evidence for the noninvolvement of M and D-Tryptamine receptors. Br. J. Pharmacol., 72, 233-237.
11. CHOPPIN, A., EGLEN, R.M. & HEDGE, S.S. (1998). Pharmacological characterization of muscarinic receptors in rabbit isolated iris sphincter muscle and urinary bladder smooth muscle. Br. J. Pharmacol., 124, 883-888.
12. 3 pharmacology. Eur. J. Pharmacol., 178, 203-213.
13. DINH XUAN, A.T., HIGENBOTTAM, T.W., CLELLAND, C., PEPKEZABA, J., WELLS, F.C. & WALLWORK, J. (1990). Acetylcholine and adenosine diphosphate cause endothelium-dependent relaxation of isolated human pulmonary arteries. Eur. Respir. J., 3, 633-638.
14. DÖRJE, F., WESS, J., LAMBRECHT, G., TACKE, R., MUTSCHLER, E. & BRANN, M.R. (1991). Antagonist binding profiles of five cloned human muscarinic receptor subtypes. J. Pharmacol. Exp. Ther., 256, 727-733.
15. DUCKLES, S.P. & GARCIA-VILLALON, A.L. (1990). Characterization of vascular muscarinic receptors: rabbit ear artery and bovine coronary artery. J. Pharmacol. Exp. Ther., 253, 608-613.
16. 3 receptors in guinea-pig ileum and atria in vitro. Br. J. Pharmacol, 109, 946-952.
17. EGLEN, R.M., HEGDE, S.S. & WATSON, N. (1996). Muscarinic receptor subtypes and smooth muscle function. Pharmacol. Rev., 48, 531-565.
18. EL-KASHEF, H. & CATRAVAS, J.D. (1991). The nature of muscarinic receptor subtypes mediating pulmonary vasoconstriction in the rabbit. Pulm. Pharmacol., 4, 8-19.
19. EL-KASHEF, H.A., HOFMAN, W.F., EHRHART, I.C. & CATRAVAS, J.D. (1991). Multiple muscarinic receptor subtypes in the canine pulmonary circulation. J. Appl. Physiol., 71, 2032-2043.
20. FURCHGOTT, R.F. & ZAWADZKI, J.V. (1980). The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature, 288, 373-376.
21. FURUTA, T., HAYAKAWA, A., IIDA, N., INAGAKI, A. & SHIGEI, T. (1987). Distribution of cholinesterase in canine venous system. Japan. J. Pharmacol., 43, 237-241.
22. GIES, J.P., BERTRAND, C., VANDERHEYDEN, P., WAELDELE, F., DUMONT, P., PAULI, G. & LANDRY, Y. (1989). Characterization of muscarinic receptors in human, guinea pig and rat lung. J. Pharmacol. Exp. Ther., 250, 309-315.
23. GILLBERG, P.G., SUNDQUIST, S. & NILVEBRANT, L. (1998). Comparison of the in vitro and in vivo profiles of tolterodine with those of subtype-selective muscarinic receptor antagonists. Eur. J. Pharmacol., 349, 285-292.
24. GREENBERG, B., RHODEN, K. & BARNES, P.J. (1987). Endothelium-dependent relaxation of human pulmonary arteries. Am. J. Physiol., 252, H434-H438.
25. HAMILTON, C.A., BERG, G., MCINTYRE, M., MCPHADEN, A.R., REID, J.L. & DOMINICZAK, A.F. (1997). Effects of nitric oxide and superoxide on relaxation in human artery and vein. Atherosclerosis, 133, 77-86.
26. HAMMER, R., BERRIE, C.P., BIRDSALL, N.J., BURGEN, A.S. & HULME, E.C. (1980). Pirenzepine distinguishes between different subclasses of muscarinic receptors. Nature, 283, 90-92.
27. JAISWAL, N., LAMBRECHT, G., MUTSCHLER, E., TACKE, R. & MALIK, K.U. (1991). Pharmacological characterization of the vascular muscarinic receptors mediating relaxation and contraction in rabbit aorta. J. Pharmacol. Exp. Ther., 258, 842-850.
28. JOLKKONEN, M., ADEM, A., HELLMAN, U., WERNSTEDT, C. & KARLSSON, E. (1995). A snake toxin against muscarinic acetylcholine receptors: amino acid sequence, subtype specificity and effect on guinea-pig ileum. Toxicon, 33, 399-410.
29. JOLKKONEN, M., VAN GIERSBERGEN, P.L., HELLMAN, U., WERNSTEDT, C. & KARLSSON, E. (1994). A toxin from the green mamba Dendroaspis angusticeps: amino acid sequence and selectivity for muscarinic m4 receptors. FEBS Lett., 352, 91-94.
30. KALSNER, S. (1989). Cholinergic constriction in the general circulation and its role in coronary artery spasm. Circ. Res., 65, 237-257.
31. KEMME, M.J., BRUNING, T.A., CHANG, P.C & VAN ZWIETEN, P.A. (1995). Cholinergic receptor-mediated responses in the arteriolar and venous vascular beds of the human forearm. Blood Press, 4, 293-299.
32. KORNISIUK, E., JERUSALINSKY, D., CERVENANSKY, C. & HARVEY, A.L. (1995). Binding of muscarinic toxins MT × 1 and MT × 2 from the venom of the green mamba Dendroaspis angusticeps to cloned human muscarinic cholinoceptors. Toxicon, 33, 11-18.
33. 4 binding sites in rabbit lung, chicken heart, and NG108-15 cells. Mol. Pharmacol., 38, 805-815.
34. LINVILLE, D.G. & HAMEL, E. (1995). Pharmacological characterization of muscarinic acetylcholine binding sites in human and bovine cerebral microvessels. Naunyn-Schmiedeberg's Arch. Pharmacol., 352, 179-186.
35. MAHDY, Z., OTUN, H.A., DUNLOP, W. & GILLESPIE, J.I. (1998). The responsiveness of isolated human hand vein endothelial cells in normal pregnancy and in pre-eclampsia. J. Physiol. (Lond), 508, 609-617.
36. MARTIN, G.R., BOLOFO, M.L. & GILES, H. (1992). Inhibition of endothelium-dependent vasorelaxalion by arginine analogues: a pharmacological analysis of agonist and tissue dependence. Br. J. Pharmacol., 105, 643-652.
37. MCCORMACK, D.G., MAK, J.C., MINETTE, P. & BARNES, P.J. (1988). Muscarinic receptor subtypes mediating vasodilation in the pulmonary artery. Eur. J. Pharmacol., 158, 293-297.
38. MILLER, J.H., AAGAARD, P.J., GIBSON, V.A. & MCKINNEY, M. (1992). Binding and functional selectivity of himbacine for cloned and neuronal muscarinic receptors. J. Pharmacol. Exp. Ther., 263, 663-667.
39. MIRANDA, H.F., BUSTAMANTE, D., CASTILLO, O., SALVATIERRA, P., SAAVEDRA, H., FERNANDEZ, E., PAEILE, C., PELISSIER, T. & PINARDI, G. (1992). Cholinergic receptors in the human vas deferens. J. Recept. Res., 12, 101-115.
40. NANDIWADA, P.A., HYMAN, A.L. & KADOWITZ, P.J. (1983). Pulmonary vasodilator responses to vagal stimulation and acetylcholine in the cat. Circ. Res., 53, 86-95.
41. NELSON, C.B., AUGELLI-SZAFRAN, C.E., CALLAHAN, M.J., CHRISTOFFERSEN, C., JAEN, J.C., MELTZER, L.T., PENVOSE, J.R., SCHWARZ, R.D., THOMAS, A.J. & WILEY, J. (1994). Pharmacological characterization of PD150714: an m1 selective muscarinic antagonist. Life Sci., 56, 11/12, 1017.
42. 3 muscarinic receptors in human pulmonary arteries. Br. J. Pharmacol., 119, 149-157.
43. NUNN, P.A., GREENGRASS, P.M., NEWGREEN, D.T., NAYLOR, A.M. & WALLIS, R.M. (1996). The binding profile of the novel muscarinic receptor antagonist darifenacin against the five cloned human muscarinic receptors expressed in CHO cells. Br. J. Pharmacol., 117, 130P.
44. O'ROURKE, S.T. & VANHOUTTE, P.M. (1987). Subtypes of muscarinic receptors on adrenergic nerves and vascular smooth muscle of the canine saphenous vein. J. Pharmacol. Exp. Ther., 241, 64-67.
45. REN, L.M., NAKANE, T. & CHIBA, S. (1993). Muscarinic receptor subtypes mediating vasodilation and vasoconstriction in isolated, perfused simian coronary arteries. J. Cardiovasc. Pharmacol., 22, 841-846.
46. RINKEN, A. (1995). Subtype-specific changes in ligand binding properties after solubilization of muscarinic receptors from baculovirus-infected Sf9 insect cell membranes. J. Pharmacol. Exp. Ther., 272, 8-14.
47. RUBANYI, G.M., MCKINNEY, M. & VANHOUTTE, P.M. (1987). Biphasic release of endothelium-derived relaxing factor(s) by acetylcholine from perfused canine femoral arteries. Characterization of muscarinic receptors. J. Pharmacol. Exp. Ther., 240, 802-808.
48. SAETRUM OPGAARD, O. & EDVINSSON, L. (1996). Effect of parasympathetic and sensory transmitters on human epicardial coronary arteries and veins. Pharmacol. Toxicol., 78, 273-279.
49. + channels involved in the inhibition of acetylcholine-induced contractions in lamb coronary small arteries. Eur. J. Pharmacol., 329, 153-163.
50. SIMONSEN, U., PRIETO, D., RIVERA, L., HERNANDEZ, M., MULVANY, M.J. & GARCIA-SACRISTAN, A. (1993). Heterogeneity of muscarinic receptors in lamb isolated coronary resistance arteries. Br. J. Pharmacol., 109, 998-1007.
51. THOM, S., HUGHES, A., MARTIN, G. & SEVER, P.S. (1987). Endothelium-dependent relaxation in isolated human arteries and veins. Clin. Sci., 73, 547-552.
52. TOGA, H., BANSAL, V. & RAJ, J.U. (1996). Differential responses of ovine intrapulmonary arteries and veins to acetylcholine. Respir. Physiol., 104, 197-204.
53. WALCH, L., TAISNE, C., GASCARD, J.P., NASHASHIBI, N., BRINK, C. & NOREL, X. (1997). Cholinesterase activity in human pulmonary arteries and veins. Br. J. Pharmacol., 121, 986-990.